Plus Therapeutics, Inc.(PSTV)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PSTV Plus Therapeutics, Inc.

已收盘 10-10 16:00:00 EDT

0.6973

-0.0253

-3.50%

盘后0.6823

-0.0150-2.15%

19:59 EDT

最高0.7000	最低0.6500	成交量1,582万
今开0.7000	昨收0.7226	日振幅6.92%
总市值6,922万	流通市值4,211万	总股本9,926万
成交额1,074万	换手率26.19%	流通股本6,039万
市净率22.81	ROE-522.50%	每股收益-2.34
52周最高2.31	52周最低0.1634	市盈率-0.30
股息0.00	股息收益率0.00	ROA-74.05%

北京优虎网络科技有限公司

{"stockData":{"symbol":"PSTV","market":"US","secType":"STK","nameCN":"Plus Therapeutics, Inc.","latestPrice":0.6973,"timestamp":1760126400000,"preClose":0.7226,"halted":0,"volume":15816376,"hourTrading":{"tag":"盘后","latestPrice":0.6823,"preClose":0.6973,"latestTime":"19:59 EDT","volume":667398,"amount":453136.47195,"timestamp":1760140784502},"delay":0,"floatShares":60392800,"shares":99264526,"eps":-2.340673,"marketStatus":"已收盘","change":-0.0253,"latestTime":"10-10 16:00:00 EDT","open":0.7,"high":0.7,"low":0.65,"amount":10740402.725755999,"amplitude":0.069195,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-2.340673,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1760342400000},"marketStatusCode":5,"adr":0,"listingDate":1134968400000,"exchange":"NASDAQ","adjPreClose":0.7226,"preHourTrading":{"tag":"盘前","latestPrice":0.676,"preClose":0.7226,"latestTime":"09:29 EDT","volume":887004,"amount":621493.87285548,"timestamp":1760102988673},"postHourTrading":{"tag":"盘后","latestPrice":0.6823,"preClose":0.6973,"latestTime":"19:59 EDT","volume":667398,"amount":453136.47195,"timestamp":1760140784502},"volumeRatio":0.558618},"requestUrl":"/m/hq/s/PSTV","defaultTab":"news","newsList":[{"id":"1119944038","title":"Plus Therapeutics, Inc.与联合健康保险公司就转移性中枢神经系统癌症Cnside®脑脊液检测达成全国覆盖协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1119944038","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119944038?lang=zh_cn&edition=full","pubTime":"2025-09-25 19:31","pubTimestamp":1758799881,"startTime":"0","endTime":"0","summary":"Plus Therapeutics, Inc.与联合健康保险公司就转移性中枢神经系统癌症Cnside®脑脊液检测达成全国覆盖协议","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1551013342.USD","LU1003077747.HKD","SG9999018865.SGD","IE00B775H168.HKD","LU0211326839.USD","LU0342679015.USD","IE0004445239.USD","LU2361044949.HKD","LU2552382215.SGD","SG9999014906.USD","IE00B4R5TH58.HKD","IE0005OL40V9.USD","BK4585","LU0128525929.USD","SGXZ99366536.SGD","LU1323610961.USD","LU1035773651.USD","LU0545039389.USD","IE0004445015.USD","IE00B4JS1V06.HKD","LU2112291526.USD","LU0354030511.USD","LU1814569148.SGD","LU1267930730.SGD","LU2491050071.SGD","LU2491049909.HKD","IE00B19Z9505.USD","LU1061106388.HKD","LU0820561909.HKD","IE00B19Z9P08.USD","LU1720051108.HKD","LU1670628061.USD","SGXZ51526630.SGD","IE0002141913.USD","LU0122379950.USD","LU0553294199.USD","IE00B1XK9C88.USD","LU0432979614.USD","LU0661504455.SGD","LU1023059063.AUD","LU0109391861.USD","LU0211327993.USD","LU0158827781.USD","LU2324357040.USD","IE0009355771.USD","LU1066051498.USD","LU0316494557.USD","LU2244417387.USD","LU1153585028.USD","IE00BFSS8Q28.SGD","LU0795875169.SGD","LU2087625088.SGD","IE00BJT1NW94.SGD","IE0002270589.USD","LU1064131342.USD","SGXZ31699556.SGD","LU0114720955.EUR","LU0795875086.SGD","LU1988902786.USD","LU2236285917.USD","IE00B1BXHZ80.USD","LU0528227936.USD","LU0965509010.AUD","LU1119994496.HKD","LU1674673691.USD","IE00BFXG1179.USD","LU0079474960.USD","SG9999001176.SGD","IE00BJJMRY28.SGD","LU0912757837.SGD","LU0738911758.USD","LU0052756011.USD","BK4154","LU0310800379.SGD","IE00B7SZLL34.SGD","LU2211815571.USD","LU0251132253.USD","LU0149725797.USD","BK4581","SG9999014880.SGD","LU1670627923.USD","LU1506573853.SGD","LU1551013425.SGD","LU2125154935.USD","LU0820561818.USD","IE00BKVL7J92.USD","LU0266013472.USD","LU0708994859.HKD","SG9999002232.USD","LU0820562030.AUD","LU2362541513.USD","LU0861579265.USD","SG9999014898.SGD","LU2089984988.USD","LU2125154778.USD","LU2271345857.HKD","SG9999002224.SGD","LU1267930227.SGD","LU0345770993.USD","LU0882574055.USD","LU0234572021.USD","LU2028103732.USD","IE00BZ9MQY76.HKD","LU0128525689.USD","LU0456855351.SGD","LU1718418525.SGD","LU1066051225.USD","UNH","LU1854103824.USD","LU0976567544.SGD","LU0029864427.USD","IE00BFTCPJ56.SGD","LU0094547139.USD","LU0345770308.USD","IE00BFSS7M15.SGD","LU1066053197.SGD","LU2361044865.SGD","LU0353189763.USD","LU2361045086.USD","LU0203345920.USD","LU0496365809.HKD","LU0310800965.SGD","IE00B19Z9Z06.USD","LU0238689110.USD","LU0943347566.SGD","BK4534","LU1267930490.SGD","LU2491050154.USD","SG9999001176.USD","LU2357305700.SGD","LU0058720904.USD","LU0097036916.USD","LU1074936037.SGD","LU1791710400.SGD","LU2468319806.SGD","IE00B19Z3581.USD","IE00BJJMRX11.SGD","BK4139","LU1084165304.USD","LU0256863811.USD","LU0689472784.USD","LU1548497426.USD","LU1732799900.SGD","LU1983299246.USD","LU2089284900.SGD","LU2347655156.SGD","LU2461242641.AUD","LU2552382058.USD","IE00BJJMRZ35.SGD","LU0011850046.USD","LU0965509283.SGD","SG9999014914.USD","IE00B894F039.SGD","IE00BWXC8680.SGD","LU0107464264.USD","LU0203347892.USD","LU0048584097.USD","LU0672654240.SGD","LU0557290698.USD","LU1674673428.USD","BK4533","LU0787776722.HKD","LU1934455863.HKD","LU0289739699.SGD","BK4566","LU0417517546.SGD","LU1069347547.HKD","LU1732800096.USD","LU0320765059.SGD","LU2552382132.HKD","LU0354030438.USD","LU0310799852.SGD","LU0683600562.USD","LU1261432733.SGD","LU2279689827.SGD","LU0187121727.USD","SG9999018857.SGD","BK4532","BK4588","LU0198837287.USD","LU1037948541.HKD","LU1057294990.SGD","LU1778281490.HKD","LU1914381329.SGD","LU0708995401.HKD","LU1267930573.SGD","LU0823416689.USD","IE000M9KFDE8.USD","LU0077335932.USD","SG9999013999.USD","LU1291159041.SGD","LU1854104046.USD","LU2111349929.HKD","LU0965508806.USD","SG9999017495.SGD","LU2023251221.USD","LU0965509101.SGD","LU1791710582.SGD","IE00BSNM7G36.USD","LU1066051811.HKD","LU2362541273.HKD","LU2360032135.SGD","SGXZ57979304.SGD","LU0211328371.USD","LU2362540622.SGD","IE00B7KXQ091.USD","LU1496350502.SGD","LU1934455277.USD","IE00BN29S564.USD","LU2089283258.USD","LU0949170772.SGD","LU1989771016.USD","PSTV","LU2242649171.HKD","LU1720051017.SGD","IE00B19Z8W00.USD","LU2133065610.SGD","LU1934455194.USD","LU0053666078.USD","LU1037948897.HKD","IE00B19Z8X17.USD","LU0211326755.USD","IE00B2B36J28.USD","IE00B19Z3B42.SGD","LU0158827948.USD","LU0353189680.USD","SGXZ81514606.USD","IE00BKPKM429.USD","IE00BZ1G4Q59.USD","LU2264538146.SGD"],"gpt_icon":0},{"id":"2541129021","title":"Ascendiant Capital：维持Plus Therapeutics评级，由买入调整至买入评级, 目标价由20.00美元调整至20.50美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2541129021","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541129021?lang=zh_cn&edition=full","pubTime":"2025-06-05 18:11","pubTimestamp":1749118309,"startTime":"0","endTime":"0","summary":"Ascendiant Capital：维持Plus Therapeutics(PSTV.US)评级，由买入调整至买入评级, 目标价由20.00美元调整至20.50美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506051816559772d461&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506051816559772d461&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PSTV","LENZ"],"gpt_icon":0},{"id":"2537376591","title":"Plus Therapeutics, Inc.盘中异动 早盘股价大涨5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537376591","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537376591?lang=zh_cn&edition=full","pubTime":"2025-05-23 22:03","pubTimestamp":1748008983,"startTime":"0","endTime":"0","summary":"北京时间2025年05月23日22时03分，Plus Therapeutics, Inc.股票出现异动，股价快速上涨5.59%。Plus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Plus Therapeutics, Inc.公司简介：Plus Therapeutics Inc是一家临床阶段制药公司，专注发现，开发和提供为癌症和罕见疾病患者提供复杂的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523220303a489ccd0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523220303a489ccd0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4539","PSTV","BK4007","PSTVZ","BK4139"],"gpt_icon":0},{"id":"2537428599","title":"Plus Therapeutics, Inc.盘中异动 股价大跌5.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537428599","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537428599?lang=zh_cn&edition=full","pubTime":"2025-05-22 21:32","pubTimestamp":1747920725,"startTime":"0","endTime":"0","summary":"北京时间2025年05月22日21时32分，Plus Therapeutics, Inc.股票出现异动，股价大幅下挫5.63%。Plus Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.10%。其相关个股中，Vigil Neuroscience, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Biodexa Pharmaceuticals Plc涨幅较大，Biodexa Pharmaceuticals Plc、Polyrizon Ltd.、Nucana Plc较为活跃，换手率分别为1247.66%、881.83%、340.66%，振幅较大的相关个股有Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Eyenovia, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025，振幅分别为24.71%、14.66%、13.17%。Plus Therapeutics, Inc.公司简介：Plus Therapeutics Inc是一家临床阶段制药公司，专注发现，开发和提供为癌症和罕见疾病患者提供复杂的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522213205a48853a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522213205a48853a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","PSTVZ","BK4007","PSTV","BK4139","BK4539"],"gpt_icon":0},{"id":"2536064513","title":"Plus Therapeutics, Inc.盘中异动 早盘股价大跌11.04%报0.298美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536064513","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536064513?lang=zh_cn&edition=full","pubTime":"2025-05-20 21:31","pubTimestamp":1747747871,"startTime":"0","endTime":"0","summary":"北京时间2025年05月20日21时31分，Plus Therapeutics, Inc.股票出现异动，股价快速跳水11.04%。Plus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。其相关个股中，Neuraxis, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Eyenovia, Inc.涨幅较大，Polyrizon Ltd.、Eyenovia, Inc.、Neuraxis, Inc.较为活跃，换手率分别为1183.55%、1170.03%、463.32%，振幅较大的相关个股有Neuraxis, Inc.、Eyenovia, Inc.、Abpro Holdings, Inc，振幅分别为22.91%、9.73%、8.64%。Plus Therapeutics, Inc.公司简介：Plus Therapeutics Inc是一家临床阶段制药公司，专注发现，开发和提供为癌症和罕见疾病患者提供复杂的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520213111a6e62275&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520213111a6e62275&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","PSTVZ","PSTV","BK4539","BK4139"],"gpt_icon":0},{"id":"2536680037","title":"Plus Therapeutics, Inc.盘中异动 股价大跌9.55%报0.380美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536680037","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536680037?lang=zh_cn&edition=full","pubTime":"2025-05-19 21:31","pubTimestamp":1747661507,"startTime":"0","endTime":"0","summary":"北京时间2025年05月19日21时31分，Plus Therapeutics, Inc.股票出现异动，股价大幅跳水9.55%。Plus Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。其相关个股中，Protagenic Therapeutics Inc C/Wts 26/04/2026 、Protagenic Therapeutics, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 涨幅较大，Polyrizon Ltd.、Protagenic Therapeutics, Inc.、Nucana Plc较为活跃，换手率分别为6967.19%、4280.76%、1962.01%，振幅较大的相关个股有Protagenic Therapeutics Inc C/Wts 26/04/2026 、再鼎医药、Generation Bio Co.，振幅分别为218.87%、105.85%、104.90%。Plus Therapeutics, Inc.公司简介：Plus Therapeutics Inc是一家临床阶段制药公司，专注发现，开发和提供为癌症和罕见疾病患者提供复杂的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519213147a6e4cfef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250519213147a6e4cfef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4539","BK4007","PSTVZ","PSTV","BK4139"],"gpt_icon":0},{"id":"2535313487","title":"Plus Therapeutics, Inc.盘中异动 早盘快速跳水9.20%报0.460美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535313487","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535313487?lang=zh_cn&edition=full","pubTime":"2025-05-16 21:31","pubTimestamp":1747402271,"startTime":"0","endTime":"0","summary":"北京时间2025年05月16日21时31分，Plus Therapeutics, Inc.股票出现波动，股价大幅跳水9.20%。Plus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。其相关个股中，Inozyme Pharma, Inc.、Affimed N.V.、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 涨幅较大，Polyrizon Ltd.、Affimed N.V.、Nucana Plc较为活跃，换手率分别为880.92%、611.08%、597.54%，振幅较大的相关个股有Rocket Pharmaceuticals Inc C/Wts 02/09/2026 、Nucana Plc、Affimed N.V.，振幅分别为22.50%、9.36%、8.70%。Plus Therapeutics, Inc.公司简介：Plus Therapeutics Inc是一家临床阶段制药公司，专注发现，开发和提供为癌症和罕见疾病患者提供复杂的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516213111a6e1b8f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250516213111a6e1b8f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","PSTVZ","LENZ","BK4007","PSTV"],"gpt_icon":0},{"id":"2535215358","title":"Plus Therapeutics, Inc.盘中异动 急速跳水5.68%报0.500美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535215358","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535215358?lang=zh_cn&edition=full","pubTime":"2025-05-15 21:34","pubTimestamp":1747316067,"startTime":"0","endTime":"0","summary":"北京时间2025年05月15日21时34分，Plus Therapeutics, Inc.股票出现波动，股价大幅下挫5.68%。Plus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。其相关个股中，Nucana Plc、Abpro Holdings, Inc、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Nucana Plc、Polyrizon Ltd.、Abpro Holdings, Inc较为活跃，换手率分别为6914.64%、1873.72%、273.17%，振幅较大的相关个股有Nucana Plc、Pasithea Therapeutics Corp.、Scpharmaceuticals Inc.，振幅分别为35.84%、20.55%、17.41%。Plus Therapeutics, Inc.公司简介：Plus Therapeutics Inc是一家临床阶段制药公司，专注发现，开发和提供为癌症和罕见疾病患者提供复杂的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515213427a6e06e0f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515213427a6e06e0f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","LENZ","BK4007","PSTVZ","PSTV"],"gpt_icon":0},{"id":"2533645936","title":"Plus Therapeutics, Inc.盘中异动 股价大涨5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533645936","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533645936?lang=zh_cn&edition=full","pubTime":"2025-05-07 21:38","pubTimestamp":1746625082,"startTime":"0","endTime":"0","summary":"北京时间2025年05月07日21时38分，Plus Therapeutics, Inc.股票出现异动，股价大幅拉升5.02%。Plus Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.36%。Plus Therapeutics, Inc.公司简介：Plus Therapeutics Inc是一家临床阶段制药公司，专注发现，开发和提供为癌症和罕见疾病患者提供复杂的治疗方法。消息层面，截至21时38分，《D. Boral Capital：下调Plus Therapeutics评级》资讯为影响Plus Therapeutics, Inc.的重要信息。该信息摘要如下：D.Boral Capital：下调Plus Therapeutics评级，由买入调整至持有评级。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507213802975205ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250507213802975205ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PSTV","BK4139","PSTVZ","LENZ"],"gpt_icon":0},{"id":"2529871738","title":"Ascendiant Capital：维持Plus Therapeutics评级，由买入调整至买入评级, 目标价由19.00美元调整至20.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2529871738","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529871738?lang=zh_cn&edition=full","pubTime":"2025-04-21 18:31","pubTimestamp":1745231502,"startTime":"0","endTime":"0","summary":"Ascendiant Capital：维持Plus Therapeutics(PSTV.US)评级，由买入调整至买入评级, 目标价由19.00美元调整至20.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042118343294dcc314&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042118343294dcc314&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","PSTV"],"gpt_icon":0},{"id":"2528700478","title":"Plus Therapeutics, Inc.4月17日成交额为34.13万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2528700478","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528700478?lang=zh_cn&edition=full","pubTime":"2025-04-18 10:24","pubTimestamp":1744943085,"startTime":"0","endTime":"0","summary":"美东时间2025年4月17日，Plus Therapeutics, Inc.成交额为34.13万美元，成交额较昨日减少59.49%，当日成交量为53.34万股。Plus Therapeutics, Inc.于2025年4月17日跌1.95%，报0.659美元，该股过去5个交易日跌16.32%，年初至今跌42.73%，过去60日跌46.02%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-17|34.13万|-59.49%|53.34万|#|2025-04-16|84.25万|-93.43%|128.74万|#|2025-04-15|1282.19万|1284.08%|1865.37万|#|2025-04-14|92.64万|186.57%|139.43万|#|2025-04-11|32.33万|-35.54%|43.69万|Plus Therapeutics Inc是一家临床阶段制药公司，专注发现，开发和提供为癌症和罕见疾病患者提供复杂的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418102454a6beb77a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418102454a6beb77a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4139","PSTVZ","PSTV"],"gpt_icon":0},{"id":"2527245720","title":"Plus Therapeutics, Inc.盘中异动 早盘股价大跌5.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527245720","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527245720?lang=zh_cn&edition=full","pubTime":"2025-04-16 21:49","pubTimestamp":1744811396,"startTime":"0","endTime":"0","summary":"北京时间2025年04月16日21时49分，Plus Therapeutics, Inc.股票出现异动，股价大幅下挫5.85%。Plus Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.05%。其相关个股中，Dermata Therapeutics Inc C/Wts 、Psyence Biomedical Ltd C/Wts 25/01/2029、Briacell Therapeutics Corp.涨幅较大，Briacell Therapeutics Corp.、Pmgc Holdings Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为426.77%、150.79%、65.16%，振幅较大的相关个股有Mei Pharma, Inc.、Quoin Pharmaceuticals Ltd、天演药业，振幅分别为29.90%、29.30%、22.50%。Plus Therapeutics, Inc.公司简介：Plus Therapeutics Inc是一家临床阶段制药公司，专注发现，开发和提供为癌症和罕见疾病患者提供复杂的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416214956a6bca7b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416214956a6bca7b3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PSTV","LENZ","BK4007","PSTVZ"],"gpt_icon":0},{"id":"2527887322","title":"Plus Therapeutics, Inc.4月15日成交额为1282.19万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527887322","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527887322?lang=zh_cn&edition=full","pubTime":"2025-04-16 10:17","pubTimestamp":1744769878,"startTime":"0","endTime":"0","summary":"美东时间2025年4月15日，Plus Therapeutics, Inc.成交额为1282.19万美元，成交额较昨日增加1284.08%，当日成交量为1865.37万股。Plus Therapeutics, Inc.于2025年4月15日涨1.8%，报0.651美元，该股过去5个交易日跌18.62%，年初至今跌43.39%，过去60日跌44.36%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-15|1282.19万|1284.08%|1865.37万|#|2025-04-14|92.64万|186.57%|139.43万|#|2025-04-11|32.33万|-35.54%|43.69万|#|2025-04-10|50.15万|-39.24%|64.34万|#|2025-04-09|82.54万|36.57%|103.29万|Plus Therapeutics Inc是一家临床阶段制药公司，专注发现，开发和提供为癌症和罕见疾病患者提供复杂的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416101803a45a768c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416101803a45a768c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PSTV","PSTVZ","BK4007","LENZ","BK4139"],"gpt_icon":0},{"id":"2527092621","title":"Plus Therapeutics, Inc.4月14日成交额为92.64万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527092621","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527092621?lang=zh_cn&edition=full","pubTime":"2025-04-15 10:14","pubTimestamp":1744683251,"startTime":"0","endTime":"0","summary":"美东时间2025年4月14日，Plus Therapeutics, Inc.成交额为92.64万美元，成交额较昨日增加186.57%，当日成交量为139.43万股。Plus Therapeutics, Inc.于2025年4月14日跌14.73%，报0.64美元，该股过去5个交易日跌22.77%，年初至今跌44.39%，过去60日跌46.26%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-14|92.64万|186.57%|139.43万|#|2025-04-11|32.33万|-35.54%|43.69万|#|2025-04-10|50.15万|-39.24%|64.34万|#|2025-04-09|82.54万|36.57%|103.29万|#|2025-04-08|60.44万|-43.83%|73.61万|Plus Therapeutics Inc是一家临床阶段制药公司，专注发现，开发和提供为癌症和罕见疾病患者提供复杂的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415101413a6bab151&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250415101413a6bab151&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PSTVZ","BK4007","LENZ","BK4139","PSTV"],"gpt_icon":0},{"id":"2526567851","title":"Plus Therapeutics, Inc.4月11日成交额为32.33万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526567851","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2526567851?lang=zh_cn&edition=full","pubTime":"2025-04-12 10:16","pubTimestamp":1744424218,"startTime":"0","endTime":"0","summary":"美东时间2025年4月11日，Plus Therapeutics, Inc.成交额为32.33万美元，成交额较昨日减少35.54%，当日成交量为43.69万股。Plus Therapeutics, Inc.于2025年4月11日跌4.71%，报0.75美元，该股过去5个交易日跌4.94%，年初至今跌34.78%，过去60日跌37.5%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-04-11|32.33万|-35.54%|43.69万|#|2025-04-10|50.15万|-39.24%|64.34万|#|2025-04-09|82.54万|36.57%|103.29万|#|2025-04-08|60.44万|-43.83%|73.61万|#|2025-04-07|107.60万|1.94%|138.31万|Plus Therapeutics Inc是一家临床阶段制药公司，专注发现，开发和提供为癌症和罕见疾病患者提供复杂的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412101703a456bfbf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412101703a456bfbf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","PSTVZ","BK4007","PSTV","BK4139"],"gpt_icon":0},{"id":"2517148026","title":"股价一夜飙涨逾300%！Plus Therapeutics(PSTV.US)肺癌患者软脑膜转移药物获FDA孤儿药认定","url":"https://stock-news.laohu8.com/highlight/detail?id=2517148026","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517148026?lang=zh_cn&edition=full","pubTime":"2025-03-07 08:49","pubTimestamp":1741308551,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，Plus Therapeutics周四表示，其针对肺癌患者软脑膜转移的治疗药物Rhenium  Obisbemeda获得美国食品药品监督管理局孤儿药认定。受此提振，该公司股价周四收涨311.43%，盘后续涨超50%。FDA授予孤儿药认定的目的在于为针对罕见疾病和病症的药物研发者提供财务激励。除了临床试验费用的税收抵免和营销申请用户费用的豁免外，开发者还可以获得长达七年的美国市场独占权。Plus Therapeutics表示，这一认定是在公司近期完成早期单剂量试验后获得的。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1258875.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4139","LENZ","PSTV"],"gpt_icon":0},{"id":"2517316983","title":"Plus Therapeutics, Inc.股价上涨63.46% 市值涨214.05万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517316983","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517316983?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:31","pubTimestamp":1741271503,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时31分，Plus Therapeutics, Inc.股票出现异动，股价快速上涨63.46%。Plus Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.63%。其相关个股中，Plus Therapeutics, Inc.、Exicure, Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 涨幅较大，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为945.74%、102.53%、48.57%，振幅较大的相关个股有Plus Therapeutics, Inc.、Entero Therapeutics Inc.、Astria Therapeutics, Inc.，振幅分别为24.20%、13.05%、11.88%。Plus Therapeutics, Inc.公司简介：Plus Therapeutics Inc是一家临床阶段制药公司，专注发现，开发和提供为癌症和罕见疾病患者提供复杂的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223143abeb7782&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223143abeb7782&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","PSTVZ","PSTV"],"gpt_icon":0},{"id":"2517989943","title":"Plus Therapeutics, Inc.盘中异动 早盘股价大涨10.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517989943","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517989943?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:31","pubTimestamp":1741185095,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时31分，Plus Therapeutics, Inc.股票出现波动，股价急速上涨10.69%。Plus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Chimerix, Inc.、Silexion Therapeutics Corp涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Zyversa Therapeutics, Inc.较为活跃，换手率分别为334.68%、252.30%、185.70%，振幅较大的相关个股有Aditxt, Inc.、Silexion Therapeutics Corp、Tango Therapeutics, Inc.，振幅分别为23.90%、13.51%、11.41%。Plus Therapeutics, Inc.公司简介：Plus Therapeutics Inc是一家临床阶段制药公司，专注发现，开发和提供为癌症和罕见疾病患者提供复杂的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223135a260c738&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223135a260c738&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PSTVZ","LENZ","PSTV","BK4139"],"gpt_icon":0},{"id":"2516963757","title":"Plus Therapeutics, Inc.盘中异动 急速跳水6.19%报0.680美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516963757","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516963757?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:50","pubTimestamp":1741013451,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时50分，Plus Therapeutics, Inc.股票出现波动，股价大幅下跌6.19%。Plus Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。其相关个股中，Bioxcel Therapeutics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Osr Holdings Inc C/Wts 09/02/2028 涨幅较大，Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为508.31%、113.64%、83.90%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Entero Therapeutics Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为140.46%、70.53%、35.60%。Plus Therapeutics, Inc.公司简介：Plus Therapeutics Inc是一家临床阶段制药公司，专注发现，开发和提供为癌症和罕见疾病患者提供复杂的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303225052a25d45b9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303225052a25d45b9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PSTVZ","PSTV","BK4139","LENZ"],"gpt_icon":0},{"id":"2514378873","title":"Plus Therapeutics, Inc.盘中异动 股价大涨5.04%报0.709美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514378873","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514378873?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:32","pubTimestamp":1740753163,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时32分，Plus Therapeutics, Inc.股票出现异动，股价大幅上涨5.04%。Plus Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。其相关个股中，Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 涨幅较大，Bioxcel Therapeutics, Inc.、Virpax Pharmaceuticals, Inc.、Enveric Biosciences, Inc.较为活跃，换手率分别为484.61%、243.09%、63.65%，振幅较大的相关个股有Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Ptc Therapeutics, Inc.、Enveric Biosciences, Inc.，振幅分别为31.14%、10.54%、9.91%。Plus Therapeutics, Inc.公司简介：Plus Therapeutics Inc是一家临床阶段制药公司，专注发现，开发和提供为癌症和罕见疾病患者提供复杂的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223244abe0eac6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223244abe0eac6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PSTV","PSTVZ","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://plustherapeutics.com","stockEarnings":[{"period":"1week","weight":0.0588},{"period":"1month","weight":0.4648},{"period":"3month","weight":1.0089},{"period":"6month","weight":-0.0365},{"period":"1year","weight":-0.4687},{"period":"ytd","weight":-0.3717}],"compareEarnings":[{"period":"1week","weight":0.0029},{"period":"1month","weight":0.032},{"period":"3month","weight":0.0762},{"period":"6month","weight":0.257},{"period":"1year","weight":0.1629},{"period":"ytd","weight":0.1452}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Plus Therapeutics, Inc.该公司于1996年7月作为一家加利福尼亚普通合伙企业而组建，并于1997年5月在特拉华成立。初期，以MacroPore Biosurgery为名而被知晓，在此之前是MacroPore。该公司是一家美国制药公司，开发具有先进平台技术的中枢神经系统（“CNS”）癌症靶向放射治疗药物。该公司的新型放射性药物制剂和治疗候选药物旨在向肿瘤提供安全有效的辐射剂量。为了实现这一点，该公司开发了药物配方的创新方法，包括用纳米脂质体和微球封装铼同位素等放射性核素。","yearOnYearQuotes":[{"month":1,"riseRate":0.652174,"avgChangeRate":0.086434},{"month":2,"riseRate":0.521739,"avgChangeRate":0.019388},{"month":3,"riseRate":0.391304,"avgChangeRate":-0.044696},{"month":4,"riseRate":0.347826,"avgChangeRate":-0.02768},{"month":5,"riseRate":0.478261,"avgChangeRate":0.361181},{"month":6,"riseRate":0.25,"avgChangeRate":-0.076657},{"month":7,"riseRate":0.416667,"avgChangeRate":-0.003883},{"month":8,"riseRate":0.291667,"avgChangeRate":-0.04175},{"month":9,"riseRate":0.541667,"avgChangeRate":-0.030103},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.051813},{"month":11,"riseRate":0.347826,"avgChangeRate":0.002696},{"month":12,"riseRate":0.391304,"avgChangeRate":-0.022353}],"exchange":"NASDAQ","name":"Plus Therapeutics, Inc.","nameEN":"Plus Therapeutics, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.3","shortVersion":"4.35.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Plus Therapeutics, Inc.(PSTV)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Plus Therapeutics, Inc.(PSTV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Plus Therapeutics, Inc.,PSTV,Plus Therapeutics, Inc.股票,Plus Therapeutics, Inc.股票老虎,Plus Therapeutics, Inc.股票老虎国际,Plus Therapeutics, Inc.行情,Plus Therapeutics, Inc.股票行情,Plus Therapeutics, Inc.股价,Plus Therapeutics, Inc.股市,Plus Therapeutics, Inc.股票价格,Plus Therapeutics, Inc.股票交易,Plus Therapeutics, Inc.股票购买,Plus Therapeutics, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Plus Therapeutics, Inc.(PSTV)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Plus Therapeutics, Inc.(PSTV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}